argenx SE
XBRU:ARGX
argenx SE
Cash from Investing Activities
argenx SE
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
argenx SE
XBRU:ARGX
|
Cash from Investing Activities
$308.2m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Pharming Group NV
AEX:PHARM
|
Cash from Investing Activities
-$129.4m
|
CAGR 3-Years
-102%
|
CAGR 5-Years
-100%
|
CAGR 10-Years
N/A
|
|
ProQR Therapeutics NV
NASDAQ:PRQR
|
Cash from Investing Activities
€4.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Uniqure NV
NASDAQ:QURE
|
Cash from Investing Activities
-$205.7m
|
CAGR 3-Years
-179%
|
CAGR 5-Years
-118%
|
CAGR 10-Years
-39%
|
|
Merus NV
NASDAQ:MRUS
|
Cash from Investing Activities
-$27m
|
CAGR 3-Years
-163%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
N
|
NewAmsterdam Pharma Company NV
NASDAQ:NAMS
|
Cash from Investing Activities
€715k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is argenx SE's Cash from Investing Activities?
Cash from Investing Activities
308.2m
USD
Based on the financial report for Dec 31, 2023, argenx SE's Cash from Investing Activities amounts to 308.2m USD.
What is argenx SE's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 3Y
-4%
The average annual Cash from Investing Activities growth rates for argenx SE have been -4% over the past three years .